Global Sodium Bicarbonate Medicine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Sodium Bicarbonate Medicine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Sodium bicarbonate is a compound used for the symptomatic treatment of heartburn, acid indigestion, and upset stomach as well as the treatment of metabolic acidosis associated with conditions such as severe renal disease and circulatory insufficiency due to shock.
Sodium Bicarbonate Medicine report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Sodium Bicarbonate Medicine market is projected to reach US$ 1343.6 million in 2029, increasing from US$ 1057 million in 2022, with the CAGR of 3.5% during the period of 2024 to 2029. Demand from Metabolic Acidosis and Hyperacidity of Stomach are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Sodium Bicarbonate Medicine industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Sodium Bicarbonate Medicine key manufacturers include AdvaCare, Pfizer, Bella Pharmaceuticals, Global Calcium, Trumac Healthcare, Exela Pharma Sciences, LLC, Bayer, Salix Pharmaceuticals, Inc and Brioschi Pharmaceuticals International, LLC, etc. AdvaCare, Pfizer, Bella Pharmaceuticals are top 3 players and held % sales share in total in 2022.
Sodium Bicarbonate Medicine can be divided into Oral Tablet and Injection, etc. Oral Tablet is the mainstream product in the market, accounting for % sales share globally in 2022.
Sodium Bicarbonate Medicine is widely used in various fields, such as Metabolic Acidosis, Hyperacidity of Stomach and Other,, etc. Metabolic Acidosis provides greatest supports to the Sodium Bicarbonate Medicine industry development. In 2022, global % sales of Sodium Bicarbonate Medicine went into Metabolic Acidosis filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Sodium Bicarbonate Medicine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
AdvaCare
Pfizer
Bella Pharmaceuticals
Global Calcium
Trumac Healthcare
Exela Pharma Sciences, LLC
Bayer
Salix Pharmaceuticals, Inc
Brioschi Pharmaceuticals International, LLC
Watson Pharmaceuticals
Hangzhou Minsheng Pharmaceutical Group Co., Ltd
Tianjin Lisheng Pharmaceutical Co., Ltd
Beijing Yanjing Pharmaceutical Co., Ltd
Sichuan Qili Pharmaceutical Co., Ltd
Jilin Aodong Pharmaceutical Group
Guangxi Banzhou Tianlong Pharmaceutical Co., Ltd
Segment by Type
Oral Tablet
Injection
Metabolic Acidosis
Hyperacidity of Stomach
Other
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Sodium Bicarbonate Medicine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Sodium Bicarbonate Medicine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Sodium Bicarbonate Medicine industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Sodium Bicarbonate Medicine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Sodium Bicarbonate Medicine introduction, etc. Sodium Bicarbonate Medicine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Sodium Bicarbonate Medicine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Sodium Bicarbonate Medicine report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Sodium Bicarbonate Medicine market is projected to reach US$ 1343.6 million in 2029, increasing from US$ 1057 million in 2022, with the CAGR of 3.5% during the period of 2024 to 2029. Demand from Metabolic Acidosis and Hyperacidity of Stomach are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Sodium Bicarbonate Medicine industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Sodium Bicarbonate Medicine key manufacturers include AdvaCare, Pfizer, Bella Pharmaceuticals, Global Calcium, Trumac Healthcare, Exela Pharma Sciences, LLC, Bayer, Salix Pharmaceuticals, Inc and Brioschi Pharmaceuticals International, LLC, etc. AdvaCare, Pfizer, Bella Pharmaceuticals are top 3 players and held % sales share in total in 2022.
Sodium Bicarbonate Medicine can be divided into Oral Tablet and Injection, etc. Oral Tablet is the mainstream product in the market, accounting for % sales share globally in 2022.
Sodium Bicarbonate Medicine is widely used in various fields, such as Metabolic Acidosis, Hyperacidity of Stomach and Other,, etc. Metabolic Acidosis provides greatest supports to the Sodium Bicarbonate Medicine industry development. In 2022, global % sales of Sodium Bicarbonate Medicine went into Metabolic Acidosis filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Sodium Bicarbonate Medicine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
AdvaCare
Pfizer
Bella Pharmaceuticals
Global Calcium
Trumac Healthcare
Exela Pharma Sciences, LLC
Bayer
Salix Pharmaceuticals, Inc
Brioschi Pharmaceuticals International, LLC
Watson Pharmaceuticals
Hangzhou Minsheng Pharmaceutical Group Co., Ltd
Tianjin Lisheng Pharmaceutical Co., Ltd
Beijing Yanjing Pharmaceutical Co., Ltd
Sichuan Qili Pharmaceutical Co., Ltd
Jilin Aodong Pharmaceutical Group
Guangxi Banzhou Tianlong Pharmaceutical Co., Ltd
Segment by Type
Oral Tablet
Injection
Segment by Application
Metabolic Acidosis
Hyperacidity of Stomach
Other
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Sodium Bicarbonate Medicine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Sodium Bicarbonate Medicine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Sodium Bicarbonate Medicine industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Sodium Bicarbonate Medicine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Sodium Bicarbonate Medicine introduction, etc. Sodium Bicarbonate Medicine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Sodium Bicarbonate Medicine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices